🔎 Trials Near Me

Beranda › Kanker Metastatik › Texas › Austin

Uji klinis Kanker Metastatik di Austin, TX

19 studi untuk Kanker Metastatik mencari peserta di lokasi sekitar Austin (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Menerima pesertaFase 3
  • Texas Oncology - Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07562152

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • NEXT Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1
  • NEXT Oncology, Austin
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06586957

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Texas Oncology - Central/South Texas, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

Menerima pesertaFase 1
  • NEXT Oncology, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07612176

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Menerima pesertaFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07218380

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Menerima pesertaFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213804

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Menerima pesertaFase 1/2
  • Texas Oncology (Balcones) - SCRI, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05267626

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Menerima pesertaFase 1/2
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07227415

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Menerima pesertaFase 1/2
  • NEXT Oncology - Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06566079

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • USO - Texas Oncology, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Menerima pesertaFase 1/2
  • Avenzo Therapeutics Recruiting Site, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07193511

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Menerima pesertaFase 1/2
  • Crinetics Study Site, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07129252

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Texas Oncology - Central/South Texas, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Menerima pesertaFase 3
  • Research Site, Austin
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • Texas Oncology - Central South, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06657144

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • University of Texas at Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Menerima pesertaFase 1/2
  • NEXT Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jan 2025 · NCT06090266

Uji klinis Kanker Metastatik di kota lain

Studi lain di Austin

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.